Anrotenib Plus Toripalimab Versus Toripalimab in Patients With Advanced Esophageal Squamous Cell Carcinoma
Clinical trial NCT04229849 · UNKNOWN
Trial details
- NCT number
- NCT04229849
- Sponsor
- Henan Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-01
- Primary completion
- 2021-01-01
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.